학술논문
Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: A randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients
Document Type
Article
Author
Source
In: Critical Care Medicine . (Critical Care Medicine, 2001, 29(3):503-510)
Subject
Language
English
ISSN
00903493